Walvax Biotechnology Co., Ltd. (SHE:300142)
11.98
-0.19 (-1.56%)
Feb 13, 2026, 3:04 PM CST
-0.25% (1Y)
| Market Cap | 19.16B +4.1% |
| Revenue (ttm) | 2.40B -22.5% |
| Net Income | 49.24M -59.8% |
| EPS | 0.03 -59.8% |
| Shares Out | 1.60B |
| PE Ratio | 389.08 |
| Forward PE | 73.72 |
| Dividend | 0.03 (0.25%) |
| Ex-Dividend Date | Jan 9, 2026 |
| Volume | 26,686,586 |
| Average Volume | 62,895,479 |
| Open | 12.21 |
| Previous Close | 12.17 |
| Day's Range | 11.97 - 12.23 |
| 52-Week Range | 9.70 - 14.65 |
| Beta | 0.57 |
| RSI | 44.51 |
| Earnings Date | Mar 28, 2026 |